Scar Zone Labeling Issues Referred To FDA Following NAD Compliance Review
This article was originally published in The Rose Sheet
Executive Summary
FDA is considering regulatory action against CCA Industries regarding certain labeling claims made on the firm's Scar Zone topical scar diminishing cream. The product is part of the Sudden Change skin care line